At Haeoreum Science, our research efforts are focused on developing products with global market competitiveness that lead the way in consumer-centric value creation within the overall diagnostic and therapeutic industry. We aim to design the company's future vision and contribute to extending human lifespan.
In 2021, we acquired hospital pathogenic gene amplification Point-of-Care Testing (POCT) diagnostic technology from the Korea Food Research Institute, enabling us to develop and advance the commercialization of the hospital pathogenic gene amplification POCT platform (diagnostic device + diagnostic kit). With the expansion of our corporate research institute and factory registration in 2023, we relocated from KAIST (Energy and Environment Research Center) to Gaon Biz Tower. We are equipped with facilities for Bio (BL2 certified) and Chemical R&D laboratories, and pilot production capabilities, solidifying our position as a comprehensive research institute.
In particular, we have developed and commercialized high-purity active pharmaceutical ingredients (API), organic compounds (OLED), catalysts, pesticides, and cosmetic raw materials. We strive to maximize customer satisfaction by establishing a systematic research system to develop products that meet customer demands and respond to market needs.
